Kodiak Sciences (KOD) Long-Term Debt Issuances (2018)
Kodiak Sciences (KOD) reported Long-Term Debt Issuances of $33.0 million for Q1 2018.
Kodiak Sciences (KOD) Long-Term Debt Issuances (2018) Analysis & Trends
Kodiak Sciences has reported Long-Term Debt Issuances for 1 years, with the latest figure at $33.0 million in Q1 2018.
- For the quarter ending Q1 2018, Long-Term Debt Issuances changed N/A year-over-year to $33.0 million; the trailing twelve-month figure through Dec 2018 stood at $33.0 million (changed N/A YoY), and the FY2018 full-year result was $33.0 million, up 230.0% from the prior year.
- Long-Term Debt Issuances for Q1 2018 stood at $33.0 million.
- The five-year high for Long-Term Debt Issuances was $33.0 million in Q1 2018, with the low at $33.0 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.73 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 33.00 Mn |
| Mar 31, 2018 | 33.00 Mn |